This finding was confirmed by immunohistochemical analysis for CD34, a marker of endothelial progenitor cells, which was found to be more intensively expressed in the tumor masses of hyponatremic mice (p ≤ 0.02 vs. control group) (Figure 5b). This evidence concerns the gene CD34 and neoplasm.